LOS ANGELES, CALIFORNIA – October 13, 2021 – GTX Corp (OTC: GTXO) (“GTX” or the “Company”), a pioneer in the field of: health & safety GPS wearable technology and provider of personal protective medical equipment and supplies, today announced it has signed a development collaboration and reseller agreement with LifeConnect, a division of Life365, an Arizona based supplier of health monitoring solutions for Remote Patient Monitoring (RPM) and Intelligent Digital Therapeutics (iDTx) designed for health care providers, employers, senior homes and other health and wellness related organizations.
Under the agreement, GTX and LifeConnect will explore integrating IoT wearable sensors into the GPS SmartSole platform which will be used as the communications gateway sending vital biometric data along with GPS coordinates to the cloud, leveraging the LifeConnect and Life365 Health backend platforms and GTX’s GPS and 4G SmartSole platform. LifeConnect and GTX will also work together to explore joint and cooperative opportunities with their respective, complementary intellectual property portfolios with a particular focus on creating a new patent protected, wearable sensor platform that allows data from a multitude of medical data sensors worn on the body to be collected at a central hub point (The GPS SmartSole) and sent to the cloud (The LifeConnect / Life365 Health portal) without the use of a smartphone.
GTX will also begin to evaluate for resale certain Life365 Health devices where GTX has established channels of distribution.
“We believe that there is an opportunity for great synergy between the two companies with their complimentary technology and I.P. portfolios, “said Andrew Duncan, GTX Corp Director, “we are looking forward to forging a close partnership and explore some near-term business opportunities.”
“Life365’s mission is to allow people, especially seniors, to live a more independent life – On their terms. Technology will play an increasing role in enabling this independence, allowing people to choose how and where they live, as well as how they engage in their own Health and Care”, said Kent Dicks, CEO of Life365. “There are over 10,000 people that turn 65 in the US every day. These people want to live in their own homes as long as they can without going into Independent or Assisted Living facilities. Life365, in conjunction with GTX can save a senior a significant amount of money by delaying their transition to a more expensive care facility and at the same time allowing them to live a more independent and safe life.”
Patrick Bertagna, GTX Corp CEO commented, “there are several opportunities we plan to explore with LifeConnect, starting with adding some of their sensors to our product offerings, integrating wearable sensors through Bluetooth to our GPS and cellular SmartSole, so that we can monitor peoples where abouts and overall health status in real time. Additionally, we are evaluating our collective IP portfolios in the wearable medical space to see how we can create a broader and more valuable portfolio.”
Many of the GTX products are available at its online store, Amazon and through domestic and international distributors. To find out more about how you can become an authorized reseller of GTX products, contact us at info@gtxcorp.com
About Life365 / LifeConnect
The Life365 Virtual Care platform integrates health systems with healthcare solution / service providers and logistics companies to deliver a one-stop, integrated platform for engaging a growing patient population at home – and beyond. The platform enables health professionals to remotely manage patients with a variety of disease states and offers consumer apps for self-managing their health and wellness. Life365 is headed by an industry recognized team with deep experience in remote healthcare technology. The founding team’s previous “Connected Health” Company was acquired by Alere (now Abbott). Life365 is also a major patent holder of the next generation of intelligent, AI driven wearables, sensors and patches that will enable the next generation of virtual care.
For more information regarding Life365, please visit www.life365.health.
For more information regarding LifeConnect, please visit www.lifeconnect.band.
MetAlert (OTC: MLRT) and its subsidiaries occupy a commanding position in the design, development, manufacturing, distribution, sales, and licensing of GPS wearable technology, asset recovery services, wandering assistive technology, and health data collection and monitoring. The Company delivers comprehensive global solutions encompassing logistics, hardware, software, and connectivity.
Notable achievements include GunAlert the world’s first all in one firearm safety solution gun lock with patented motion sensor and GPS theft recovery. And the groundbreaking GPS SmartSole®, a fusion of Dr. Scholl’s comfort with LoJack’s tracking prowess. It stands as the world’s inaugural invisible wearable tracking device, designed for individuals susceptible to wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based model thrives on technology innovation fortified by intellectual property safeguards. The company boasts international distribution channels serving customers across 40 countries, alongside its role as a U.S. Military Government contractor. In addition to public health entities, MetAlert caters to municipalities, emergency and law enforcement agencies, private educational institutions, assisted living facilities, NGOs, senior care residences, consumers, and small enterprises.
General information, investor relations, wholesale licensing, consumer purchase:
213.489.3019 | Info@MetAlert.com | IR@MetAlert.com | Contact Us
MetAlert.com | Mygunalert.com | Track My Workforce | GPS SmartSole.com
MetAlert United Kingdom– In the UK, MetAlert operates from its London office.
Please contact: Nelson Skip Riddle | Email: NSRiddle@MetAlert.com | Tel: +44 7785 364100
Level 2 Security (Wholly owned subsidiary) Email: contactus@level2sec.com | www.mygunalert.com | www.ifitmoves.com
Forward Looking Statements
This news release contains forward-looking statements. The terms and phrases “expects,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by MetAlert considering its experience and perception of current conditions and expected future developments, as well as other factors that MetAlert believes are appropriate in the circumstances. Many factors could cause MetAlert’s actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are outlined in MetAlert’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained on the SEC Website). These factors should be considered carefully, and readers should not rely on MetAlert’s forward-looking statements. MetAlert has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required.
Disclaimer: MetAlert does not warrant or represent that the unauthorized use of materials drawn from this document’s content will not infringe the rights of third parties who are not owned or affiliated by MetAlert. Further, MetAlert cannot be held responsible or liable for the unauthorized use of this document’s content by third parties unknown to the company.